IBB0979

DRUG2 trials

Sponsors

SUNHO（China）BioPharmaceutical CO., Ltd.

Conditions

Advanced Malignant TumorsSmall Cell Lung Cancer

Phase 1

A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors

RecruitingNCT05991583

SUNHO（China）BioPharmaceutical CO., Ltd.Advanced Malignant Tumors

Start: 2023-07-03End: 2025-12-30Target: 25Updated: 2025-01-17

Phase 2

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

Not yet recruitingNCT07076095

SUNHO（China）BioPharmaceutical CO., Ltd.Small Cell Lung Cancer

Start: 2025-08-01End: 2031-08-01Target: 200Updated: 2025-07-21